Q4-22-one-pager (002)


Biotage AB End of Year Report 2022

Feb 15, 2023 9:41:19 AM / by Biotage

Tomas Blomquist, President and CEO: Even though the end of the year was less satisfactory than we would have wanted, I can still say that 2022 was the best year in our 25-year history. Biotage grew rapidly, with profitability and strong cash flow. During the year, we recorded several records: net sales of more than SEK 400 million in a quarter and an operating profit of more than SEK 300 million for the year. For the full year, our net sales amounted to SEK 1,566 million.

To sum up, we are now putting a fantastic but also challenging year behind us. Our growth and positive results have contributed to opportunities to invest in new, complementary businesses in attractive niches, which in turn equips us for continued growth and even better results. Most importantly, it allows us to contribute even more to solving important challenges for society. None of this would have been possible without all the fantastic employees at Biotage, who put their heart and soul into achieving our goals every day. I would like to take this opportunity to thank them, as well as our customers and shareholders, who put their trust in us. We look forward to continued positive development together in 2023!

Read the full results in this announcement.

Topics: Sweden, News, HumanKind Unlimited


Written by Biotage

Learn From Future Blog Posts